[{"orgOrder":0,"company":"Wellbeam Consumer Health","sponsor":"Carlin Consumer Health","pharmaFlowCategory":"D","therapeuticArea":"Rheumatology","country":"U.S.A","productType":"Large molecule","year":"2024","type":"Acquisition","leadProduct":"Arnica Montana","moa":"","graph1":"Rheumatology","graph2":"Approved","graph3":"Wellbeam Consumer Health","amount2":0,"highestDevelopmentShortName":"Approved","therapeuticAreaShortName":"Rheumatology","amount2New":0,"dosageForm":"Cream","sponsorNew":"Wellbeam Consumer Health \/ Carlin Consumer Health","highestDevelopmentStatusID":"12","companyTruncated":"Wellbeam Consumer Health \/ Carlin Consumer Health"}]

Find Clinical Drug Pipeline Developments & Deals for Bendectin

Menu
Xls
Filters Filter
×
FILTER:
filter
Company Name
filter

Year

filter

DEALS // DEV.

filter

Country

filter
Sponsor
filter

Therapeutic Area

filter

Study Phase

filter

Deal Type

filter

Product Type

filter

Dosage Form

filter

Lead Product

filter

Target

Therapeutic Area by Lead Product

ForexGraph

Study Phase by Lead Product

ForexGraph

Company by Lead Product

ForexGraph

Top Deals by Deal Size (USD bn)

ForexGraph

01

Wellbeam Consumer Health

Country arrow
Pharmatech Expo 2025
Not Confirmed

Wellbeam Consumer Health

Country arrow
Pharmatech Expo 2025
Not Confirmed

Details : Through the acquisition, Carlin expands its OTC portfolio with Penetrex, a formulation using natural ingredients like Arnica and Vitamin B6 for joint and muscle pain.

Brand Name : Penetrex

Molecule Type : Large molecule

Upfront Cash : Undisclosed

April 30, 2024

Lead Product(s) : Arnica Montana,Pyridoxine Hydrochloride,Dimethyl Sulfone

Therapeutic Area : Rheumatology

Highest Development Status : Approved

Sponsor : Carlin Consumer Health

Deal Size : Undisclosed

Deal Type : Acquisition

blank